Marc Bonneville
Overview
Explore the profile of Marc Bonneville including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
3613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Llitjos J, Carrol E, Osuchowski M, Bonneville M, Scicluna B, Payen D, et al.
Crit Care
. 2024 Jul;
28(1):238.
PMID: 39003476
Implementation of biomarkers in sepsis and septic shock in emergency situations, remains highly challenging. This viewpoint arose from a public-private 3-day workshop aiming to facilitate the transition of sepsis biomarkers...
2.
Wu F, Gu Y, Kang B, Heskia F, Pachot A, Bonneville M, et al.
Transl Lung Cancer Res
. 2021 Jul;
10(6):2441-2451.
PMID: 34295653
Background: Recent breakthroughs in therapies with immune checkpoint inhibitors (ICIs) have revolutionized the treatment of lung cancer. However, only 15-25% of patients respond to the ICIs therapy, and methods to...
3.
4.
Peigne C, Leger A, Gesnel M, Konczak F, Olive D, Bonneville M, et al.
J Immunol
. 2017 May;
198(11):4228-4234.
PMID: 28461569
Vγ9Vδ2 T lymphocytes are the major human peripheral γδ T cell subset, with broad reactivity against stressed human cells, including tumor cells. Vγ9Vδ2 T cells are specifically activated by small...
5.
Marlin R, Pappalardo A, Kaminski H, Willcox C, Pitard V, Netzer S, et al.
Proc Natl Acad Sci U S A
. 2017 Mar;
114(12):3163-3168.
PMID: 28270598
Human γδ T cells comprise a first line of defense through T-cell receptor (TCR) recognition of stressed cells. However, the molecular determinants and stress pathways involved in this recognition are...
6.
Dore J, Multon M, Behier J, Affagard H, Andremont A, Barthelemy P, et al.
Therapie
. 2017 Feb;
72(1):1-19.
PMID: 28214070
No abstract available.
7.
Rettman P, Willem C, Volteau C, Legrand N, Chevallier P, Lode L, et al.
Transplantation
. 2016 Nov;
101(9):2092-2101.
PMID: 27798515
Background: Natural killer (NK) cell alloreactivity is favored after double umbilical cord blood transplantation (dUCBT) in which cord blood (UCB) units and patients are often HLA class I mismatched. Generally,...
8.
Jarry U, Chauvin C, Joalland N, Leger A, Minault S, Robard M, et al.
Oncoimmunology
. 2016 Jul;
5(6):e1168554.
PMID: 27471644
Glioblastoma multiforme (GBM) represents the most frequent and deadliest primary brain tumor. Aggressive treatment still fails to eliminate deep brain infiltrative and highly resistant tumor cells. Human Vγ9Vδ2 T cells,...
9.
Hesnard L, Legoux F, Gautreau L, Moyon M, Baron O, Devilder M, et al.
Eur J Immunol
. 2015 Dec;
46(3):560-9.
PMID: 26635029
In the thymus, a T-cell repertoire able to confer protection against infectious and noninfectious agents in a peptide-dependent, self-MHC-restricted manner is selected. Direct detection of Ag-specific thymocytes, and analysis of...
10.
Apetoh L, Smyth M, Drake C, Abastado J, Apte R, Ayyoub M, et al.
Oncoimmunology
. 2015 Jul;
4(4):e998538.
PMID: 26137416
Whereas preclinical investigations and clinical studies have established that CD8 T cells can profoundly affect cancer progression, the underlying mechanisms are still elusive. Challenging the prevalent view that the beneficial...